EUVIMEDEUVIMED entdecken
Crossref

Necrosis as a strong independent prognostic factor required in the implementation of pathological reporting for pancreatic adenocarcinoma resection specimens

Tanguy Fenouil, Pierre Marie Lavrut, Maud Rabeyrin, Mustapha Adham, Kayvan Mohkam, Jean Yves Mabrut, Thomas Walter, Valerie Hervieu

Pathology - Research and Practice · 2023

DOI: 10.1016/j.prp.2023.154406 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology - Research and Practice, 2023. Verfasst von Tanguy Fenouil und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hospices Civils de Lyon, Claude-Bernard Lyon 1 University, Institute of Pathology, Lyon, France,. Electronic address: tanguy.fenouil@chu-lyon.fr. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Adenocarcinoma, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Pancreatic ductal adenocarcinoma (PDAC) is a major public health issue with an incidence/mortality ratio reaching 98 %. Only 15-20 % of patients with PDAC can undergo surgery. Following PDAC surgical resection, 80 % of patients will experience local or metastatic recurrence of this disease. pTNM staging is the gold standard for risk stratification but is not sufficient to recapitulate the prognosis. Several prognostic factors are known to impact survival after surgery when uncovered during pathological examination. However, necrosis has been poorly studied in pancreatic adenocarcinoma. MATERIALS & METHODS: We retrieved clinical data and reviewed all tumor slides from patients who had a pancreatic surgery between January 2004 and December 2017, in the Hospices Civils de Lyon, to assess the presence of histopathological prognosis factors associated with poor prognosis. RESULTS: 514 patients with complete clinico-pathological description were included. Necrosis was found in 231 PDAC (44.9 %) and had an important impact on overall survival with a double risk of death when present in tumor samples (HR: 1.871, 95 % CI [1.523; 2.299], p < 0.001). When integrated in the multivariate model, necrosis is the only morphological aggressive feature to retain high statistical significance associated with the TNM staging but independently of it. This effect is independent of the preoperative treatment. CONCLUSIONS: Despites improvement in treatment of PDAC, mortality rates remain relatively stable amongst the last years. There is a desperate need to better stratify patients. Here, we report the strong and prognostic impact of necrosis in surgical PDAC samples and encourage pathologists to report its presence in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsAdenocarcinomaCarcinoma, Pancreatic DuctalHumansPrognosisNecrosisRetrospective Studies

Stichwörter der Autor:innen

AdenocarcinomaNecrosisOverall survivalPancreatic cancerPrognostic factor

Autor:innen und Institutionen

  • Hospices Civils de Lyon, Claude-Bernard Lyon 1 University, Institute of Pathology, Lyon, France,. Electronic address: tanguy.fenouil@chu-lyon.fr.
  • Hospices Civils de Lyon, Claude-Bernard Lyon 1 University, Institute of Pathology, Lyon, France.
  • Hospices Civils de Lyon, Claude-Bernard Lyon 1 University, Department of Digestive Surgery, Edouard Herriot Hospital, Lyon, France.
  • Hospices Civils de Lyon, Croix-Rousse University Hospital, Claude-Bernard Lyon 1 University, Department of General Surgery & Liver Transplantation, Lyon, France.
  • Hospices Civils de Lyon, Claude-Bernard Lyon 1 University, Department of hepato-gastroenterology and digestive medical oncology, Edouard Herriot Hospital, Lyon, France.

Zitieren

APA

Fenouil, T., Lavrut, P. M., Rabeyrin, M., Adham, M., Mohkam, K., Mabrut, J. Y., Walter, T., & Hervieu, V. (2023). Necrosis as a strong independent prognostic factor required in the implementation of pathological reporting for pancreatic adenocarcinoma resection specimens. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2023.154406

Vancouver

Fenouil T, Lavrut PM, Rabeyrin M, Adham M, Mohkam K, Mabrut JY, et al. Necrosis as a strong independent prognostic factor required in the implementation of pathological reporting for pancreatic adenocarcinoma resection specimens. Pathology - Research and Practice. 2023. doi:10.1016/j.prp.2023.154406

BibTeX
@article{Fenouil2023,
  author = {Fenouil, Tanguy and Lavrut, Pierre Marie and Rabeyrin, Maud and Adham, Mustapha and Mohkam, Kayvan and Mabrut, Jean Yves and Walter, Thomas and Hervieu, Valerie},
  title = {Necrosis as a strong independent prognostic factor required in the implementation of pathological reporting for pancreatic adenocarcinoma resection specimens},
  journal = {Pathology - Research and Practice},
  year = {2023},
  doi = {10.1016/j.prp.2023.154406}
}
Kostenlos starten →